GleamWall
中文EN

ETRA Electra Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 2088082 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets4.4%
Debt / equity0.00x
Current ratio23.97x
Interest coverage—

Cash quality & payout

Operating cash flow / net income—
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q32025-09-302025Q22025-06-302025Q12025-03-31
Income statement
Revenue——————
R&D expense$17.27M——$14.90M——
Operating income-$25.06M——-$17.02M——
Interest expense$0——$1.30M——
Net income-$23.93M-$26.75M-$22.17M-$18.09M-$17.57M-$7.79M
EPS (basic)-3.47——-616.86——
EPS (diluted)-3.47——-616.86——
Weighted avg. shares (diluted)6.89M——29,329——
Balance sheet
Cash & equivalents$256.41M—————
Short-term investments$146.13M—————
Current assets$406.93M—————
PP&E, net$518,000—————
Total assets$410.82M—————
Current liabilities$16.98M—————
Long-term debt$0—————
Total debt$0—————
Total liabilities$17.92M—————
Shareholders' equity$392.90M-$219.46M-$184.35M-$145.51M-$127.72M-$110.59M
Net debt-$256.41M—————
Shares outstanding62.87M—————
Cash flow statement
Operating cash flow——————
Stock-based compensation$4.59M——$302,000——

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.